Clinical Trials on Dementia, Mild in New Zealand

Total 958 results

NeuroActiva, Inc.

Completed

A Double-Blind, Placebo-Controlled Safety and Efficacy Study of NA-831

Neurocognitive Disorders | Neurodegenerative Diseases | Cognitive Impairment | Alzheimer Disease | Tauopathies | Mild Cognitive Impairment | Dementia, Vascular | Dementia With Lewy Bodies | Alzheimer Dementia | Cognitive Disorder

New Zealand
CuraSen Therapeutics, Inc.

Active, not recruiting

A Study of CST-103 Co-administered With CST-107 in Subjects With Neurodegenerative Disorders (CLIN-011)

Mild Cognitive Impairment, Lewy Body Dementia, Parkinson's Disease Rapid Eye Movement Sleep Behavior Disorder, Parkinson's Disease Dementia

Australia, New Zealand, United Kingdom
Cognito Therapeutics, Inc.

Active, not recruiting

Multi-Center Study of Sensory Stimulation to Improve Brain Function (Overture)

Cognitive Impairment | Dementia | Alzheimer Disease | Mild Cognitive Impairment | Cognitive Decline | Dementia, Alzheimer Type | Dementia Alzheimers | Dementia of Alzheimer Type | Cognitive Impairment, Mild | Dementia, Mild

United States
University of Western Sydney

Active, not recruiting

Computer-based Cognitive Rehabilitation Program for Healthy Older Adults, Older People With Mild Cognitive Impairment and Mild Dementia

Mild Cognitive Impairment | Mild Dementia | Healthy Older Adults

Australia
University of Western Sydney

Completed

Memory Encoding Strategies for People With Mild Cognitive Impairments

Mild Cognitive Impairment | Mild Dementia

Hong Kong, Australia
Cognito Therapeutics, Inc.

Enrolling by invitation

Extension to a Pivotal Study of Sensory Stimulation in Alzheimer's Disease (OLE Hope Study, CA-0015)

Cognitive Impairment | Alzheimer Disease | Mild Cognitive Impairment | Dementia Alzheimers | Dementia of Alzheimer Type | AD | Dementia, Mild | Dementia Moderate

United States
New York University
NYU Langone Health; Duke University; National Institutes of Health (NIH); National... and other collaborators

Completed

Care Partner Assisted Intervention to Improve Oral Health of Individuals With Mild Dementia

Mild Dementia

United States
University of Massachusetts, Amherst
University of Maryland, Baltimore; Yale University; National Institute on Aging... and other collaborators

Active, not recruiting

Cognitive Stimulation Therapy for Dementia: A Two-Armed Pragmatic Trial

Dementia | Dementia, Vascular | Dementia, Mixed | Dementia With Lewy Bodies | Dementia of Alzheimer Type | Cognitive Impairment, Mild | Dementia, Mild | Dementia Moderate | Dementia Frontal

United States
NYU Langone Health
Alzheimer's Association

Recruiting

Innate Immunity Stimulation Via TLR9 in Early AD

Mild Cognitive Impairment | Alzheimer Dementia

United States
CuraSen Therapeutics, Inc.

Completed

A Study of CST-2032 and CST-107 in Subjects With Mild Cognitive Impairment or Mild Dementia Due to Parkinson's or Alzheimer's Disease

Dementia | Mild Cognitive Impairment

United States, New Zealand
Sage Therapeutics

Active, not recruiting

A Study to Evaluate the Effects of SAGE-718 in Participants With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease (AD)

Mild Cognitive Impairment | Alzheimer's Disease | Mild Dementia

United States, Puerto Rico
APRINOIA Therapeutics, LLC

Active, not recruiting

Evaluation of [18F]APN-1607 PET Uptake in Alzheimer's Disease Patients Compared With Healthy Subjects

Healthy Volunteers | Alzheimer's Disease | Mild Cognitive Impairment Due to Alzheimer's Disease

United States
Actinogen Medical

Recruiting

Effect of 10 mg Xanamem on Dementia Due to Alzheimer's Disease (XanaMIA)

Alzheimer Disease | Dementia, Mild | Dementia Moderate

Australia
Baycrest

Completed

A Pilot Study for the Brain Health Support Program (CTU BHSP-P)

Dementia | Mild Cognitive Impairment | Dementia Prevention | Subjective Cognitive Impairment | Pre-dementia

Canada
Cognito Therapeutics, Inc.

Recruiting

A Pivotal Study of Sensory Stimulation in Alzheimer's Disease (Hope Study, CA-0011) (Hope)

Cognitive Impairment | Dementia | Alzheimer Disease | Mild Cognitive Impairment | Cognitive Decline | Alzheimer Disease, Early Onset | Alzheimer Disease, Late Onset | MCI | Dementia Alzheimers | Mild Dementia | Dementia of Alzheimer Type | Cognitive Impairment, Mild | Alzheimer Disease 1 | Dementia, Mild | Alzheimer... and other conditions

United States
AstraZeneca

Completed

A Study of the Safety and Tolerability of AZD5213 Effect on Sleep for Patients With Alzheimer's/Cognitive Impairment

Mild Cognitive Impairment | Mild Alzheimer's Disease

United States
Taipei Hospital, Ministry of Health and Welfare

Recruiting

Repeated Transcranial Magnetic Stimulation in the Elderly With Cognitive Impairment

Dementia | Cognitive Impairment, Mild

Taiwan
Albert Einstein College of Medicine
National Institute of Neurological Disorders and Stroke (NINDS)

Completed

5-Cog Battery for Detecting Cognitive Impairment and Dementia (5-Cog)

Neurocognitive Disorders | Cognitive Impairment | Dementia | Mild Cognitive Impairment

United States
Baycrest

Active, not recruiting

Brain Health Support Program (CTU: BHSP)

Cognitive Change | Mild Cognitive Impairment | Dementia Prevention | Subjective Cognitive Impairment

Canada
New York State Psychiatric Institute
National Institutes of Health (NIH); National Institute on Aging (NIA)

Completed

Olfactory Deficits and Donepezil Treatment in Cognitively Impaired Elderly

Alzheimer Disease | Mild Cognitive Impairment | Delirium, Dementia, Amnestic, Cognitive Disorders

United States
Columbia University
Boston University; Johns Hopkins University; University of California, Berkeley; University of Miami and other collaborators

Recruiting

Metformin in Alzheimer's Dementia Prevention (MAP)

Mild Cognitive Impairment

United States
Aptinyx
CogState Ltd.; Worldwide Clinical Trials

Active, not recruiting

NYX-458 in Subjects With Mild Cognitive Impairment or Mild Dementia Due to Parkinson's Disease or Lewy Body Dementia (Cognition, Memory, Attention, Thinking)

Parkinson Disease | Mild Cognitive Impairment | Lewy Body Disease | Mild Dementia

United States
German Center for Neurodegenerative Diseases (DZNE)
University of Siegen; Gesundheitsregion Siegerland eG (GRS); Alzheimer Gesellschaft... and other collaborators

Recruiting

Implementing Dementia Care Management Into Routine Care in the Region Siegen-Wittgenstein (RoutineDeCM)

Dementia | Mild Cognitive Impairment | Dementia Alzheimers | Care Management

Germany
University of Southern California
National Institute on Aging (NIA); Alzheimer's Therapeutic Research Institute; Wake Forest University Health Sciences

Completed

The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)

Alzheimer's Disease | Amnestic Mild Cognitive Impairment

United States
Biogen

Recruiting

A Study to Learn About the Safety of BIIB080 and Whether it Can Improve Symptoms of Participants With Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild AD Dementia Between 50 to 80 Years of Age (CELIA)

Mild Cognitive Impairment Due to Alzheimer's Disease | Alzheimer's Disease Dementia

Belgium, United States, Australia, Italy, Spain, Denmark, United Kingdom, Czechia, France, Poland, Switzerland, Germany, Canada, Japan, Finland, Netherlands, Sweden
Neuroscience Trials Australia
The Florey Institute of Neuroscience and Mental Health

Active, not recruiting

Deferiprone to Delay Dementia (The 3D Study)

Mild Cognitive Impairment | Prodromal Alzheimer's Disease | Mild Alzheimer's Disease

Australia
University of Southern California
National Institute on Aging (NIA); Northern California Institute of Research... and other collaborators

Completed

Alzheimer's Disease Neuroimaging Initiative 2 (ADNI2)

Mild Cognitive Impairment (MCI) | Alzheimer's Disease (AD) | Significant Memory Concern (SMC) | Early Mild Cognitive Impairment (EMCI) | Late Mild Cognitive Impairment (LMCI)

United States, Canada
Icahn School of Medicine at Mount Sinai

Recruiting

Music Therapy Experiences in Patients With Mild Cognitive Impairment (MCI) and Alzheimer's Disease (AD)

Mild Cognitive Impairment | Alzheimer's Disease

United States
Weill Medical College of Cornell University

Active, not recruiting

The Comparative Effectiveness Dementia & Alzheimer's Registry (CEDAR)

Alzheimer Disease | Mild Cognitive Impairment

United States
Icahn School of Medicine at Mount Sinai
National Institute on Aging (NIA)

Recruiting

7T MRI for Light Therapy in Patients With Mild Cognitive Impairment and Mild AD

Mild Cognitive Impairment | Alzheimer's Disease

United States
Weill Medical College of Cornell University
National Institute on Aging (NIA)

Completed

PET Measures of CSF Clearance in Preclinical Alzheimer's Disease

Mild Cognitive Impairment

United States
NYU Langone Health

Terminated

A Proof of Concept Study of the Prevention of Mild Cognitive Impairment and Eventual Alzheimer's Disease Using F18 Flutemetamol

Alzheimer Disease

United States
Duke University
National Heart, Lung, and Blood Institute (NHLBI); National Institute on Aging... and other collaborators

Recruiting

Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults (PREVENTABLE)

Cardiovascular Diseases | Dementia | Cognitive Impairment, Mild

United States, Puerto Rico
Icahn School of Medicine at Mount Sinai

Recruiting

Phase 2 - Rhythmic Light Therapy for Alzheimer's Disease Patients

Mild Cognitive Impairment

United States
Icahn School of Medicine at Mount Sinai
National Institute on Aging (NIA); Rutgers University

Recruiting

The Long-term Impact of a Light Intervention on Sleep and Cognition in Mild Cognitive Impairment

Mild Cognitive Impairment | Alzheimer's Disease

United States
Icahn School of Medicine at Mount Sinai

Completed

Rhythmic Light Therapy for Alzheimer's Disease Patients

Mild Cognitive Impairment

United States
The Mind Research Network

Completed

Enhancing Memory in Mild Cognitive Impairment and Early Stage Alzheimer's Disease (MEMORI)

Alzheimer Disease | Mild Cognitive Impairment

United States
Icahn School of Medicine at Mount Sinai

Recruiting

A Light Exposure Tracker Designed to Improve Circadian Rhythms - Aim 1

Mild Cognitive Impairment | Alzheimer's Disease

United States
Icahn School of Medicine at Mount Sinai

Active, not recruiting

Understanding Circadian Responses to Light in Persons With Mild Cognitive Impairment

Alzheimer Disease | Mild Cognitive Impairment

United States
Taipei Medical University Shuang Ho Hospital

Completed

The Effects of Intermittent Theta Burst Stimulation in MCI and Early AD

Alzheimer Disease | Mild Cognitive Impairment | Cognitive Decline

Taiwan
Janssen-Cilag Pty Ltd

Completed

Prospective Research in Memory Clinics (PRIME)

Dementia | Mild Cognitive Impairment

Australia
Zealand University Hospital
University of Copenhagen; Technical University of Denmark; OptoCeutics

Completed

Study on Safety, Feasibility and Neural Activation of Non-Invasive Light Therapy System (ALZLIGHT Pilot)

Alzheimer Disease

Denmark
iPACES LLC
Albany Medical College; 1st Playable Productions; Pacific Brain Health Center; Adirondack...

Recruiting

The Interactive Physical and Cognitive Exercise System (v3) for Mild Cognitive Impairment (MCI) (iPACES)

Dementia | Alzheimer Disease | Mild Cognitive Impairment | MCI

United States
Union College, New York
US Department of Veterans Affairs

Completed

Effects of Strengthening Exercise on the Brain for Early Dementia and Normative Older Adults

Dementia | Mild Cognitive Impairment | Cognitive Decline | Alzheimer's Disease

United States
Takeda
Zinfandel Pharmaceuticals Inc.

Terminated

Biomarker Qualification for Risk of Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease (AD) and Safety and Efficacy Evaluation of Pioglitazone in Delaying Its Onset (TOMMORROW)

Mild Cognitive Impairment Due to Alzheimer's Disease

United States, Germany, Switzerland, United Kingdom, Australia
NYU Langone Health
National Institutes of Health (NIH); Alzheimer's Association; LiteCure LLC

Recruiting

Transcranial Photobiomodulation for Alzheimer's Disease (TRAP-AD)

Alzheimer Disease | Mild Cognitive Impairment

United States
Eisai Inc.
Biogen

Terminated

Dose-Finding Study To Evaluate Safety, Tolerability, and Efficacy of E2609 in Participants With Mild Cognitive Impairment Due to Alzheimer's Disease (Prodromal Alzheimer's Disease) and Mild to Moderate Dementia Due to Alzheimer's Disease

Alzheimer Disease | Dementia, Alzheimer Type

United States
Oryzon Genomics S.A.
Alzheimer's Drug Discovery Foundation

Completed

Testing the Safety and Preliminary Efficacy of the New Drug ORY-2001 in Mild to Moderate Alzheimer's Disease (ETHERAL-US)

Mild to Moderate Alzheimer's Disease

United States
Eli Lilly and Company

Completed

A Study of Donanemab (LY3002813) Compared With Aducanumab in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 4)

Mild Cognitive Impairment (MCI) | Alzheimer Disease

United States
Weill Medical College of Cornell University
National Institute on Aging (NIA); Tolmar Pharmaceuticals

Recruiting

The LUCINDA Trial: LeUprolide Plus Cholinesterase Inhibition to Reduce Neurological Decline in Alzheimer's (LUCINDA)

Alzheimer Disease | Mild Cognitive Impairment

United States

Clinical Trials on Dementia, Mild in New Zealand

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Guatemala

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations